Table of Contents
CPCRA GART Study (046) A Randomized Study of Antiretroviral Management Based on Plasma Genotypic Antiretroviral Resistance Testing (GART) in Patients Failing Antiretroviral Therapy
Study Design
Algorithm For Interpretation Of Resistance Mutations: RTIs
Algorithm For Interpretation Of Resistance Mutations: PIs
Baseline GART Report
Baseline Characteristics
Distribution of Major Mutations
Impact of GART Report on RegimenPrescribed in the GART Group
HIV RNA (log10) Change from Baseline
Mean HIV RNA by Study Week
Percent of Patients with Undetectable HIV RNA, by Study Week
HIV RNA Changes byNumber of Active Drugs Prescribed
No. Drugs Prescribedby Randomization Group
PPT Slide
PPT Slide
PPT Slide
Change in HIV RNA (from Baseline to Average of 4 and 8 Weeks) Associated with Selected Protease Mutations
Conclusion
Conclusions (continued)
Protocol Team
|